ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2026
Multinational stakeholder engagement to inform future development and refinement of the EuroQol toddler and infant populations (EQ-TIPS).
Article in The European journal of health economics : HEPAC : health economics in prevention and care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Impact of inactivated influenza vaccination on health-related quality of life for young children using Japanese experimental EuroQol toddler and infant populations (EQ-TIPS) v2.0.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026Article
- Developing the EuroQol toddler and infant populations (EQ-TIPS) instrument: qualitative analysis of expert views on content validity and conceptual challenges.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThe EQ-TIPS (v2.0) is an experimental instrument to measure and value the HRQoL in children aged 0-3 years. This study consulted experts and caregivers to (a) review the instrument's wording and content for global relevance; (b) assess the need for additional dimensions; (c) identify potential challenges in measuring HRQoL in young children.
methodsParticipants included 26 HRQoL experts, 28 child health and development experts, and 65 caregivers of young children, recruited through snowballing and international networks. Participants completed online surveys, with analyses involving thematic assessment of open-ended responses and frequency reporting of closed-ended responses.
resultsEQ-TIPS v2.0 was positively received with participants recognising its potential value in clinical practice, health research and policymaking. There was limited consensus amongst experts regarding the use of the term 'age-appropriate' within the EQ-TIPS dimensions. Concern was highlighted regarding the perceived overlap between social interaction and communication; and whether in their currently worded forms they are distinct enough to warrant being separate dimensions. Furthermore, respondents questioned whether the dimensions are sensitive enough to account for the nuances of a child's abilities across the age range. It was suggested that introducing examples across all dimensions would decrease this subjectivity of proxy reporting and reduce the global differences in perceptions of dimensions. Additional dimensions suggested for further investigation at the multinational level were sleep and emotional functioning.
conclusionFurther multinational development of the EQ-TIPS will be guided by expert and caregiver input, with proposed descriptive system modifications to be qualitatively tested in subsequent research.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.